Variable | Odds ratio | 95% confidence interval | P value |
---|---|---|---|
First model | |||
Hematological malignancy, cancer, or non-malignant hematological abnormality known on admission | 3.70 | [1.44–9.33] | 0.007 |
Indication of BMA excluding isolated TPa,b | 3.69 | [1.46–9.30] | 0.006 |
SOFA scorec | 1.15 | [1.04–1.28] | 0.006 |
Pre-BMA HScorec,d | 1.03 | [1.02–1.04] | < 0.001 |
Second model | |||
Hematological malignancy, cancer, or non-malignant hematological abnormality known on admission | 3.21 | [1.78–8.76] | 0.023 |
Indication of BMA excluding isolated TPa,b | 4.53 | [1.66–12.38] | 0.003 |
SOFA—platelet-count SOFA subscorec | 1.15 | [1.03–1.29] | 0.013 |
Pre-BMA HScorec,d | 1.03 | [1.02–1.04] | < 0.001 |
Platelet count SOFA subscore 0 versus other groupsc | 2.38 | [0.76-7.50] | 0.138 |